GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSUY) » Definitions » Cyclically Adjusted PB Ratio

Embla Medical hf (Embla Medical hf) Cyclically Adjusted PB Ratio : 3.57 (As of May. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Embla Medical hf Cyclically Adjusted PB Ratio?

As of today (2024-05-01), Embla Medical hf's current share price is $4.50. Embla Medical hf's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $1.26. Embla Medical hf's Cyclically Adjusted PB Ratio for today is 3.57.

The historical rank and industry rank for Embla Medical hf's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSSUY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.58   Med: 5.06   Max: 8.12
Current: 2.8

During the past years, Embla Medical hf's highest Cyclically Adjusted PB Ratio was 8.12. The lowest was 2.58. And the median was 5.06.

OSSUY's Cyclically Adjusted PB Ratio is ranked worse than
60.65% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 2.125 vs OSSUY: 2.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Embla Medical hf's adjusted book value per share data for the three months ended in Mar. 2024 was $1.714. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.26 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Embla Medical hf Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Embla Medical hf's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cyclically Adjusted PB Ratio Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.63 6.54 5.21 3.63 2.66

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.23 3.24 2.82 2.66 3.21

Competitive Comparison of Embla Medical hf's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted PB Ratio falls into.



Embla Medical hf Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Embla Medical hf's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.50/1.26
=3.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Embla Medical hf's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.714/142.1253*142.1253
=1.714

Current CPI (Mar. 2024) = 142.1253.

Embla Medical hf Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.028 98.777 1.479
201409 1.032 98.734 1.486
201412 0.998 98.669 1.438
201503 0.949 99.612 1.354
201506 1.011 100.289 1.433
201509 1.033 100.607 1.459
201512 1.041 100.657 1.470
201603 1.053 101.115 1.480
201606 1.037 101.923 1.446
201609 1.062 102.457 1.473
201612 1.067 102.562 1.479
201703 1.025 102.768 1.418
201706 1.089 103.496 1.495
201709 1.120 103.871 1.532
201712 1.168 104.481 1.589
201803 1.165 105.600 1.568
201806 1.172 106.206 1.568
201809 1.200 106.727 1.598
201812 1.260 108.388 1.652
201903 1.248 108.702 1.632
201906 1.295 109.758 1.677
201909 1.301 109.922 1.682
201912 1.337 110.588 1.718
202003 1.281 111.019 1.640
202006 1.254 112.667 1.582
202009 1.307 113.772 1.633
202012 1.356 114.542 1.683
202103 1.371 115.833 1.682
202106 1.420 117.451 1.718
202109 1.439 118.723 1.723
202112 1.472 120.398 1.738
202203 1.485 123.555 1.708
202206 1.463 127.809 1.627
202209 1.432 129.810 1.568
202212 1.513 131.901 1.630
202303 1.542 135.674 1.615
202306 1.578 139.150 1.612
202309 1.606 140.147 1.629
202312 1.670 142.125 1.670
202403 1.714 142.125 1.714

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Embla Medical hf  (OTCPK:OSSUY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Embla Medical hf Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (Embla Medical hf) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.